Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort
Stephen I Rennard1, Nicholas Locantore, Bruno Delafont
11 Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
Annals of the American Thoracic Society
|February 3, 2015
Summary
Cluster analysis identified five distinct chronic obstructive pulmonary disease (COPD) subgroups. These subgroups exhibit varying clinical features, outcomes, and inflammatory profiles, suggesting unique COPD subtypes.
Area of Science:
- Pulmonary Medicine
- Clinical Research
- Biostatistics
Background:
- Chronic obstructive pulmonary disease (COPD) is recognized as a heterogeneous condition.
- Understanding clinically relevant subgroups within COPD is crucial for effective management.
Purpose of the Study:
- To identify distinct subgroups of COPD patients within the ECLIPSE cohort using cluster analysis.
- To evaluate the clinical outcomes and relationships among variables within these identified subgroups over a 3-year follow-up period.
Main Methods:
- Factor analysis reduced 41 baseline variables from 2,164 COPD patients to 13 key factors.
- Cluster analysis was performed using variables with the highest factor loadings.
- Subgroups were assessed for their association with clinically meaningful outcomes and internal parameter relationships over 3 years.
Main Results:
- Five distinct COPD subgroups were identified based on cross-sectional clinical features.
- Significant differences in mortality, hospitalizations, systemic inflammation, comorbidities, emphysema extent, and exacerbation rates were observed among the clusters.
- Cluster D showed the highest exacerbation and COPD hospitalization rates, while Cluster C had the highest mortality.
- Cluster A represented patients with milder disease and fewer adverse events.
- Cluster E appeared to be a mixed group, potentially encompassing further distinct subgroups.
Conclusions:
- Cluster analysis of baseline data successfully identified five COPD subgroups within the ECLIPSE study.
- These subgroups demonstrate differential outcomes, inflammatory biomarkers, and interrelationships among clinical parameters.
- The findings suggest that these clusters represent clinically and biologically distinct subtypes of COPD, paving the way for more personalized treatment strategies.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
2
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
2
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
2
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.4K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.4K